TD Private Client Wealth’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $27.7K | Sell |
|
|||||
|
2025
Q1 | $48.2K | Buy |
|
|||||
|
2024
Q4 | $41.8K | Buy |
|
|||||
|
2024
Q3 | $35.8K | Buy |
|
|||||
|
2024
Q2 | $26.7K | Buy |
|
|||||
|
2024
Q1 | $21.7K | Buy |
|
|||||
|
2023
Q4 | $13.6K | Buy |
|
|||||
|
2023
Q3 | $10.4K | Buy |
|
|||||
|
2023
Q2 | $9.19K | Buy |
|
|||||
|
2023
Q1 | $7.78K | Buy |
|
|||||
|
2022
Q4 | $6.83K | Buy |
|
|||||
|
2022
Q3 | $4.75K | Hold |
|
|||||
|
2022
Q2 | $4.64K | Hold |
|
|||||
|
2022
Q1 | $4.32K | Sell |
|
|||||
|
2021
Q4 | $6.18K | Buy |
|
|||||
|
2021
Q3 | $3.09K | Sell |
|
|||||
|
2021
Q2 | $4K | Buy |
|
|||||
|
2021
Q1 | $2.79K | Buy |
|
|||||
|
2020
Q4 | $1.93K | Buy |
|
|||||
|
2020
Q3 | $1.37K | Buy |
|
|||||
|
2020
Q2 | $987 | Sell |
|
|||||
|
2020
Q1 | $2.96K | Hold |
|
|||||
|
2019
Q4 | $2.96K | Buy |
|